FdaApplication

ANDA 212977

Back to search

Identifiers

Properties

PropertyValue
applicant_nameXIROMED PHARMA ESPANA SL
application_typeANDA
approval_date2020-12-10

Products (3)

ProductActive ingredientStrengthDosage form
OMEPRAZOLEOMEPRAZOLE40MGCAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLEOMEPRAZOLE20MGCAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLEOMEPRAZOLE10MGCAPSULE, DELAYED REL PELLETS;ORAL

3 products